trial · primary record
Levornidazole Disodium Phosphate for Injection
Mass Balance Study
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 6 |
| Primary completion | 2025-02-14 |
| Primary endpoint | Cumulative Percent Recovery of Total Radiocarbon (14C) |
| Registry ID | NCT07906197 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:20.342Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07906197
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.